These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19222513)

  • 1. Long-term safety of biologics in dermatology.
    Lima XT; Seidler EM; Lima HC; Kimball AB
    Dermatol Ther; 2009; 22(1):2-21. PubMed ID: 19222513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
    van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
    Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
    [No Abstract]   [Full Text] [Related]  

  • 4. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D; Strober BE
    Semin Cutan Med Surg; 2010 Mar; 29(1):28-34. PubMed ID: 20430305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics in dermatology: adverse effects.
    Sehgal VN; Pandhi D; Khurana A
    Int J Dermatol; 2015 Dec; 54(12):1442-60. PubMed ID: 26147909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric psoriasis: updates in biologic therapies.
    Sukhatme SV; Gottlieb AB
    Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of biologics in dermatology.
    Castelo-Soccio L; Van Voorhees AS
    Dermatol Ther; 2009; 22(1):22-33. PubMed ID: 19222514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of biological agents in dermatology].
    Huryń A; Bielecka-Grzela S; Klimowicz A; Zejmo M
    Ann Acad Med Stetin; 2007; 53(2):8-13; discussion 13. PubMed ID: 18557371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label uses of biologic agents in dermatology: a 2006 update.
    Kerns MJ; Graves JE; Smith DI; Heffernan MP
    Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy in pediatrics: a developing field.
    Mathis L; Rodriguez W
    Dermatol Ther; 2009; 22(3):257-61. PubMed ID: 19453350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biologics in the treatment of moderate-to-severe plaque psoriasis.
    Puig L
    G Ital Dermatol Venereol; 2017 Feb; 152(1):28-35. PubMed ID: 27627100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction.
    Gottlieb AB
    Dermatol Ther; 2009; 22(1):1. PubMed ID: 19222512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of the products of bee-keeping in dermatology].
    Romanenko GF; Fomina LP; Mozherenkov VP
    Vestn Dermatol Venerol; 1981 Jul; (7):25-8. PubMed ID: 7027677
    [No Abstract]   [Full Text] [Related]  

  • 16. Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis.
    de la Cueva Dobao P; Notario J; Ferrándiz C; López Estebaranz JL; Alarcón I; Sulleiro S; Borrás J; Daudén E; Carrascosa JM; Sánchez Carazo JL; Monte Boquet E; Puig L
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1214-1223. PubMed ID: 31037770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation.
    Butler DC; Heller MM; Murase JE
    J Am Acad Dermatol; 2014 Mar; 70(3):417.e1-10; quiz 427. PubMed ID: 24528912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics in dermatology: What does the future hold?
    Yavuz C
    Dermatol Ther; 2019 Jul; 32(4):e12932. PubMed ID: 30977240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing trends for biologic drugs among Ohio dermatologists.
    Iacullo J; Kunzler E; Ezaldein HH; Scott JF
    Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.